Baharudin et al. found that recurrent CRC patients exhibited higher methylation levels and the recurrence of CRC compared to non‐recurrent CRC patients, which might associate with the abnormal methylation of CCNEI, CCNDBP1, CHL1, DDX43, and PON3. Here, CHL1 is linked to colorectal carcinoma.